Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

U.S. Army Won’t Punish Chaplain for Criticizing Biden Transgender Policy

U.S. Army chaplain Major Andrew Calvert received a formal…
Read more

Israel Creates World’s First Laser Capable of Shooting Down Incoming Rockets

Israel has successfully tested an airborne laser weapon that…
Read more